http://harvardscience.harvard.edu/stories/person/875 Stories and external links referencing a person (RSS) en http://harvardscience.harvard.edu/medicine-health/articles/drug-hits-new-molecular-target-mice <!--paging_filter--><p>When doctors diagnose and plan treatment for breast cancers they look for various indicators of how aggressive they are and what treatments will work best. Two-thirds of breast tumors are made up of cells that have receptor molecules for estrogen on their cell surface. The growth of these estrogen-receptor-positive (ER+) tumors depends in part on estrogen in the woman's body. Treatment for these cancers, along with surgery, usually involves a hormone blocker such as tamoxifen. But there's no such method to treat ER- tumors, which are independent of estrogen. So researchers at Dana-Farber Cancer Institute have been searching for other ways to stem their uncontrolled growth. Debajit K. Biswas, research associate at Harvard Medical School and senior associate in the laboratory of Arthur B.</p> <p><a href="http://harvardscience.harvard.edu/medicine-health/articles/drug-hits-new-molecular-target-mice">read more</a></p> Mon, 26 Mar 2007 05:13:35 -0400 70652986 2986 at http://harvardscience.harvard.edu